1963•JAMARequires access

Treatment of Meprobamate Withdrawal Syndrome

Bent Florian Sørensen

Open publisher page 0 citations

Abstract

I can approve of the statement in "Death After Withdrawal of Meprobamate" that "similar clinical courses may occur in the terminal stages of fatal withdrawal of barbiturates and meprobamate." The authors recommend that in case of abuse meprobamate be withdrawn slowly, and if convulsions occur they recommend that dosage be increased and then again reduced over a longer period. Most psychiatrists in Denmark would do otherwise. According to our experience symptoms arising after abrupt withdrawal of short-acting barbiturates or of meprobamate are best treated with phenobarbital, 0.1-0.3 gm, given three times a day for two or three days. After this period phenobarbital is slowly withdrawn.

About this research paper

What this paper is about

I can approve of the statement in "Death After Withdrawal of Meprobamate" that "similar clinical courses may occur in the terminal stages of fatal withdrawal of barbiturates and meprobamate." The authors recommend that in case of abuse meprobamate be withdrawn slowly, and if convulsions occur they recommend that dosage be increased and then again reduced over a longer period. Most psychiatrists in Denmark would do otherwise. According to our experience symptoms arising after abrupt withdrawal of short-acting barbiturates or of meprobamate are best treated with phenobarbital, 0.1-0.3 gm, given three times a day for two or three days. After this period phenobarbital is slowly withdrawn.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

I can approve of the statement in "Death After Withdrawal of Meprobamate" that "similar clinical courses may occur in the terminal stages of fatal withdrawal of barbiturates and meprobamate." The authors recommend that in case of abuse meprobamate be withdrawn slowly, and if convulsions occur they recommend that dosage be increased and then again reduced over a longer period. Most psychiatrists in Denmark would do otherwise. According to our experience symptoms arising after abrupt withdrawal of short-acting barbiturates or of meprobamate are best treated with phenobarbital, 0.1-0.3 gm, given three times a day for two or three days. After this period phenobarbital is slowly withdrawn.

Key concepts: Meprobamate, Medicine, Phenobarbital, Withdrawal syndrome, Anesthesia, Pharmacology

Related papers

Back to paper searchBrowse research topicsOriginal source
Treatment of Meprobamate Withdrawal Syndrome — Research Paper | ScholarLens